These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9708415)

  • 1. Immune markers and viral load after HIV-1 seroconversion as predictors of disease progression in a cohort of haemophilic men.
    Sabin CA; Devereux H; Phillips AN; Janossy G; Loveday C; Lee CA
    AIDS; 1998 Jul; 12(11):1347-52. PubMed ID: 9708415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.
    Spijkerman IJ; Prins M; Goudsmit J; Veugelers PJ; Coutinho RA; Miedema F; de Wolf F
    AIDS; 1997 Sep; 11(11):1383-8. PubMed ID: 9302449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up.
    Phillips AN; Sabin CA; Elford J; Bofill M; Lee CA; Janossy G
    AIDS; 1993 Jul; 7(7):975-80. PubMed ID: 8102854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Weng S; Carrington M; Mellors J; Rinaldo CR; Mann D; Apple R; Phair JP; Detels R; O'Brien S; Enger C; Johnson P; Kaslow RA
    AIDS; 1998 Nov; 12(16):2107-13. PubMed ID: 9833851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor excision circles and HIV-1 2-LTR episomal DNA to predict AIDS in patients not receiving effective therapy.
    Goedert JJ; O'Brien TR; Hatzakis A; Kostrikis LG;
    AIDS; 2001 Nov; 15(17):2245-50. PubMed ID: 11698697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.
    de Wolf F; Spijkerman I; Schellekens PT; Langendam M; Kuiken C; Bakker M; Roos M; Coutinho R; Miedema F; Goudsmit J
    AIDS; 1997 Dec; 11(15):1799-806. PubMed ID: 9412697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.
    Kostrikis LG; Touloumi G; Karanicolas R; Pantazis N; Anastassopoulou C; Karafoulidou A; Goedert JJ; Hatzakis A;
    J Virol; 2002 Oct; 76(20):10099-108. PubMed ID: 12239284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
    Hazenberg MD; Otto SA; van Benthem BH; Roos MT; Coutinho RA; Lange JM; Hamann D; Prins M; Miedema F
    AIDS; 2003 Sep; 17(13):1881-8. PubMed ID: 12960820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.
    Katzenstein TL; Pedersen C; Nielsen C; Lundgren JD; Jakobsen PH; Gerstoft J
    AIDS; 1996 Feb; 10(2):167-73. PubMed ID: 8838704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surrogate markers for disease progression in treated HIV infection.
    Ghani AC; de Wolf F; Ferguson NM; Donnelly CA; Coutinho R; Miedema F; Goudsmit J; Anderson RM
    J Acquir Immune Defic Syndr; 2001 Nov; 28(3):226-31. PubMed ID: 11694828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
    Merigan TC; Hirsch RL; Fisher AC; Meyerson LA; Goldstein G; Winters MA
    AIDS; 1996 Feb; 10(2):159-65. PubMed ID: 8838703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.
    Mellors JW; Muñoz A; Giorgi JV; Margolick JB; Tassoni CJ; Gupta P; Kingsley LA; Todd JA; Saah AJ; Detels R; Phair JP; Rinaldo CR
    Ann Intern Med; 1997 Jun; 126(12):946-54. PubMed ID: 9182471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study.
    Sabin CA; Griffioen A; Yee TT; Emery VC; Herrero-Martinez E; Phillips AN; Lee CA
    Lancet; 2002 Nov; 360(9345):1546-51. PubMed ID: 12443592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group.
    Shearer WT; Easley KA; Goldfarb J; Rosenblatt HM; Jenson HB; Kovacs A; McIntosh K
    J Allergy Clin Immunol; 2000 Sep; 106(3):559-66. PubMed ID: 10984378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.
    O'Brien TR; Blattner WA; Waters D; Eyster E; Hilgartner MW; Cohen AR; Luban N; Hatzakis A; Aledort LM; Rosenberg PS; Miley WJ; Kroner BL; Goedert JJ
    JAMA; 1996 Jul; 276(2):105-10. PubMed ID: 8656501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users.
    Carbone J; Gil J; Benito JM; Navarro J; Muñóz-Fernández A; Bartolomé J; Zabay JM; López F; Fernández-Cruz E
    AIDS; 2000 Dec; 14(18):2823-9. PubMed ID: 11153663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels.
    Ullum H; Lepri AC; Katzenstein TL; Phillips AN; Skinhøj P; Gerstoft J; Pedersen BK
    Scand J Infect Dis; 2000; 32(4):371-6. PubMed ID: 10959644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study.
    Touloumi G; Hatzakis A; Rosenberg PS; O'Brien TR; Goedert JJ
    AIDS; 1998 Sep; 12(13):1691-7. PubMed ID: 9764790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.